Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Frequently asked questions
What sector does Acarix A/S (ACARIX) operate in?
Acarix A/S belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Acarix A/S (ACARIX) current stock price?
As of the latest data, Acarix A/S stock price is SEK 0.26, with a previous close of SEK 0.26. Acarix A/S lost -SEK 0.00 in the last trading session, representing a -0.19% loss.
What is Acarix A/S (ACARIX) current market capitalization?
Acarix A/S market cap is approximately 306.37 million.
What is Acarix A/S (ACARIX) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.04.
What is Acarix A/S (ACARIX) EBITDA?
Acarix A/S EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -7.72 million.
Does Acarix A/S (ACARIX) pay dividends?
No. Acarix A/S does not pay a dividend.
What is Acarix A/S (ACARIX) beta (volatility) score?
Acarix A/S has a beta of -0.211, indicating lower volatility than the overall market.
